Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
KHTRF
Primary Symbol:
T.GUD
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jul 12, 2022 9:13am
RE:New NCIB in place on the 14th
Exactly ! ------------------------- "Groundhog Day" as it pertains to the way Goodman/Samira operate. They are very consistent. ------------------------- Sure we'd all like to
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Post by
EbbFlow88
on Jul 12, 2022 8:22am
New NCIB in place on the 14th
So, as of June 30th we now have 114.6M shares outstanding. 79.9M of which are public float. On thursday, we can now buy up to 7.99M shares. As Mugsy has mentioned before as well as a few others
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 12, 2022 7:30am
New Press Release - Knight Announces Normal Course Issuer Bid
MONTREAL, July 12, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company "), a leading pan-American (ex-US) specialty pharmaceutical company, announced today acceptance by the Toronto Stock Exchange (the "TSX") of the Company's Notice of Intention to Make a Normal...
read article.
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Jul 11, 2022 12:40pm
Hahahaha watch this guys. Its coming
(127)
•••
Catscratch
X
View Profile
View Bullboard History
Comment by
Catscratch
on Jul 11, 2022 12:32pm
RE:RE:RE:Bought back 196,000 shares
There are also been sizable insider buying over the past couple of years. A lot of stock is either getting bought/cancelled or landing in long term accounts (insiders, Armoyan, smart value funds
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Jul 08, 2022 7:29am
RE:RE:Bought back 196,000 shares
The current NCIB should be maxed out by now as they were able to buy and cancel 10.6M shares. That expires around July 12-13, so we should see next week that they are renewing the NCIB for 2022.
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Jul 08, 2022 5:32am
RE:Bought back 196,000 shares
Interesting, the buybacks have effectively stopped? I hope that's a sign of there being an attractive acquisition target. Perhaps they've found even better uses for the money. :)
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Comment by
GoldenInvestor
on Jul 07, 2022 9:24pm
RE:Bought back 196,000 shares
WOW! & we are making money & new drugs launched! GI
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jul 07, 2022 9:15pm
Bought back 196,000 shares
Filed 2022-07-07 14:09 Tx date 2022-06-30 $GUD Knight Therapeutics Inc. Knight Therapeutics Inc. 1 - Issuer Direct Ownership
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Jul 06, 2022 3:36pm
RE:$364,xxx
I think it's more like $134,500 because it shows as counted twice. Regardless, it's great to see him continually picking up more shares and I think you're bang on about what he sees as the
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jul 06, 2022 1:51pm
$364,xxx
Closer approximation. Apologies.
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jul 06, 2022 1:47pm
$415,000 approximately
is a pretty awesome / sizeable buy-in from the top!
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jul 06, 2022 1:37pm
The Gist of whats happening…
An accomplished pharma executive/ capital allocator, multinational entrepreneur seems to really believe what he has created and what the team and he are building upon! he gets to see what is
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jul 06, 2022 1:25pm
more buying ...
The data isn't entered properly (as per totals) but you get the gist of what's going on. : ) Filed 2022-07-05 16:57 Tx date 2022-07-04
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario